北京德恒（重庆）律师事务所 关于北大医药股份有限公司 2026 年第一次临时股东会的 法律意见 重庆市江北区江北嘴聚贤岩广场 9 号国华金融中心大厦 A 栋 24 层 电话:023-63012200 传真:023-63012211 邮编:400024 北京德恒（重庆）律师事务所 关于北大医药股份有限公司 2026年第一次临时股东会的法律意见 北京德恒（重庆）律师事务所 关于北大医药股份有限公司 2026 年第一次临时股东会的 法律意见 德恒 15G20260004-00002 号 致：北大医药股份有限公司 北大医药股份有限公司（以下简称"公司"）2026 年第一次临时股东会（以 下简称"本次会议"）于 2026 年 1 月 28 日下午 15 点召开。北京德恒（重庆）律 师事务所（以下简称"德恒"）受公司委托，指派田晶律师、夏浩云律师（以下简 称"德恒律师"）出席了本次会议。根据《中华人民共和国证券法》（以下简称"《证 券法》"）、《中华人民共和国公司法》（以下简称"《公司法》"）、中国证券 监督管理委员会《上市公司股东会规则》（以下简称"《股东会规则》"）、《北 大医药股份有限公司章程》（以下简称"《公司章 ...

Group 1 - Dongtong Tui (formerly Dongfang Tong) officially delisted from the stock exchange on January 22, 2026, due to financial fraud, having inflated revenue by 432 million and profit by 314 million from 2019 to 2022 [1][17] - The stock price at delisting was 1.72 yuan, a decline of over 96% from its historical high of 43 yuan, affecting approximately 46,000 shareholders [1][17] - The company may transition to the "old three boards" for trading, where liquidity is low and further price declines are expected [1][12] Group 2 - ST Asia Pacific announced an expected loss of 51.46 million yuan for 2025, marking its third consecutive year of losses, with a negative net asset value of 0.318 yuan per share [4][14] - ST Changyao's stock has been below 1 yuan for 15 consecutive trading days, with a market value of 223 million yuan, facing imminent delisting risks due to financial misconduct [4][18] - ST Aowei's stock has experienced 25 consecutive trading days of declines, with a market value currently at 281 million yuan, indicating a high likelihood of delisting [6][18] Group 3 - A significant wave of share reductions occurred on January 21, with 23 companies announcing plans to reduce holdings, including 7 companies with reductions exceeding 3% of total shares [6][12] - Notable reductions include Wentai Technology planning to reduce 3739.95 million shares (3% of total shares) for an estimated amount of 1.517 billion yuan, and Jingchen Co. planning to reduce 1310 million shares (3.11% of total shares) for approximately 1.219 billion yuan [8][10] - The market is witnessing a divergence, with some stocks reaching new highs while others, particularly those at risk of delisting, continue to decline [12][14]

（北大医药公告） 近日，北大医药发布公告称，公司持股5%以上的股东北大医疗管理有限责任公司因自身资金需求，计划自公告披露之 日起15个交易日后的3个月内（即2026年2月11日至2026年5月10日），通过集中竞价和大宗交易方式减持公司股份不 超过178.80万股（占公司总股本比例为3%）。 其中，集中竞价交易在任意连续90个自然日内不超过公司总股本的1%，大宗交易不超过2%。 ...

Group 1 - Northeast Securities expects a net profit of 1.477 billion yuan in 2025, a year-on-year increase of 69.06% [1] - Gansu Energy anticipates a net profit of 1.95 billion to 2.1 billion yuan in 2025, representing a year-on-year growth of 18.6% to 27.72% [2] - Ningbo Bank reports a projected net profit of 29.333 billion yuan in 2025, with an 8.13% year-on-year increase [3] Group 2 - Qianyuan Power forecasts a net profit of 567 million to 633 million yuan in 2025, indicating a year-on-year growth of 160% to 190% [5] - Batian Co. expects a net profit of 890 million to 980 million yuan in 2025, reflecting a year-on-year increase of 117.53% to 139.53% [6] - Tongfu Microelectronics anticipates a net profit of 1.1 billion to 1.35 billion yuan in 2025, with a year-on-year growth of 62.34% to 99.24% [7] Group 3 - Zhongyuan Nepe expects a net profit of 368 million to 428 million yuan in 2025, representing a year-on-year increase of 80.47% to 109.9% [8] - Huajin Co. predicts a net loss of 1.6 billion to 1.9 billion yuan in 2025, compared to a loss of 2.795 billion yuan in the previous year [9] - Xinghua Co. anticipates a net loss of 420 million to 560 million yuan in 2025, up from a loss of 380 million yuan in the previous year [4] Group 4 - Huayuan Holdings expects a net profit of 107 million to 118 million yuan in 2025, a year-on-year increase of 50.98% to 66.82% [12] - Taishan Petroleum forecasts a net profit of 130 million to 165 million yuan in 2025, indicating a year-on-year growth of 30.88% to 66.11% [13] - Jiuqi Software anticipates a net profit of 40 million to 60 million yuan in 2025, recovering from a loss of 156 million yuan in the previous year [21] Group 5 - Jin Fang Energy expects a net profit of 109 million to 143 million yuan in 2025, reflecting a year-on-year increase of 123.97% to 193.7% [16] - He Sheng New Materials anticipates a net profit of 152 million to 171 million yuan in 2025, representing a year-on-year growth of 55% to 75% [24] - Yuedong Microelectronics predicts a net loss of 340 million to 425 million yuan in 2025 [14] Group 6 - Aibo Medical plans to acquire at least 51% of Demai Medical, with an estimated valuation of the target company not exceeding 1 billion yuan [26] - Zhaoshang Shipping intends to build four 3000TEU container ships with a total investment of no more than 1.324 billion yuan [18] - Zhongtung High-tech's subsidiary has confirmed an increase in mineral resources, adding significant quantities of tungsten and other metals [27]

Group 1: Delisting Risks - *ST Xin Yan: The Shenzhen Stock Exchange has approved the company's application to revoke the delisting risk warning due to restructuring [1] - *ST Zhong Zhuang (Rights Protection): The delisting risk warning has been revoked, but other risk warnings will continue, and the stock will be suspended for one day starting tomorrow [2] - ST Sai Wei: Expected to incur a loss of 720 million to 1.02 billion yuan in 2025, with a possibility of being subject to delisting risk warnings [3] Group 2: Earnings Forecasts - Hikvision: Expected net profit attributable to shareholders to grow by 18.46% year-on-year in 2025 [28] - Langzi Co.: Expected net profit to increase by 245.25% to 302.8% year-on-year in 2025 [4][30] - Zhaoyan New Drug: Expected net profit to increase by 214% to 371% year-on-year in 2025 [5][30] - Huachen Equipment: Expected net profit to increase by 193.64% to 242.04% year-on-year in 2025 [6][30] - Qianyuan Power: Expected net profit to increase by 160% to 190% year-on-year in 2025 [7][30] - Jin Fang Energy: Expected net profit to increase by 123.97% to 193.7% year-on-year in 2025 [8][31] - Zhongfu Industrial: Expected net profit to increase by 120.27% to 141.59% year-on-year in 2025 [9][32] - Batian Co.: Expected net profit to increase by 117.53% to 139.53% year-on-year in 2025 [10][32] - Zhongrong Electric: Expected net profit to increase by 104.89% to 131.10% year-on-year in 2025 [11][32] - Kaisheng New Materials: Expected net profit to increase by 96.47% to 150.06% year-on-year in 2025 [12][32] - Putailai: Expected net profit to increase by 93.18% to 101.58% year-on-year in 2025 [13][32] - Dongfang Iron Tower: Expected net profit to increase by 91.4% to 125.07% year-on-year in 2025 [14][32] - Pulaike: Expected net profit to increase by 89.64% to 110.11% year-on-year in 2025 [15][32] - Huabang Health: Expected profit of 660 million to 730 million yuan in 2025, turning from loss to profit [16][32] - Hongyuan Green Energy: Expected net profit of 180 million to 250 million yuan in 2025, turning from loss to profit [17][32] - Kangda New Materials: Expected profit of 125 million to 135 million yuan in 2025, turning from loss to profit [18][32] - Langxin Technology: Expected profit of 100 million to 150 million yuan in 2025, turning from loss to profit [19][32] - Hualv Biological: Expected profit of 100 million to 130 million yuan in 2025, turning from loss to profit [20][32] Group 3: Mergers and Acquisitions - Kangxin New Materials: Plans to acquire 51% of Yubang Semiconductor for 392 million yuan [21][32] - Aibo Medical: Plans to gain control of Demei Medical [22][32] Group 4: Share Buybacks and Reductions - Hengtong Co.: Plans to repurchase company shares worth 80 million to 100 million yuan [24][32] - Haier Smart Home: Plans to repurchase D shares up to 200,000 euros [29][32] - Blue Universe Co.: Shareholders plan to reduce their holdings by no more than 3.02% [29][32] - Hesheng Silicon Industry: Controlling shareholder plans to reduce holdings by no more than 3% [29][32] - Aolian Electronics (Rights Protection): Shareholder Liu Junsheng plans to reduce holdings by no more than 3% [29][32] - Bluefeng Biochemical: Hainan Wenqin plans to reduce holdings by no more than 3% [29][32] - Zhixin Precision: Shareholders plan to reduce holdings by no more than 3% [29][32] - Peking University Medical: Peking University Health plans to reduce holdings by no more than 3% [29][32] Group 5: Other Updates - Liou Co.: Self-inspection work has been completed, and the stock will resume trading on January 21 [29][32] - Yongxing Materials: The lithium mica green intelligent and efficient lithium extraction project has reached production capacity [29][32] - Debang Co.: Plans to voluntarily withdraw A shares from trading on the Shanghai Stock Exchange [29][32]

股东北大医疗管理有限责任公司保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示：持有北大医药（000788）股份有限公司（以下简称"公司"）股份63,918,175股（占公司总股 本比例为10.7247%）的股东北大医疗管理有限责任公司（以下简称"北大医疗"）计划自本公告披露之日 起15个交易日后的3个月内（即2026年2月11日至2026年5月10日）以集中竞价和大宗交易方式减持公司 股份不超过17,879,622股（若此期间公司有送股、资本公积金转增股本等股份变动事项，将对该数量进 行相应调整），占公司总股本比例为3%。其中，通过集中竞价方式减持的，在任意连续90个自然日 内，减持股份总数不超过公司股份总数的1%；通过大宗交易方式减持的，在任意连续90个自然日内， 减持股份总数不超过公司股份总数的2%。 公司于近日收到持股5%以上股东北大医疗《关于计划减持北大医药股份有限公司股份的告知函》，北 大医疗拟减持公司股份。根据《上市公司股东减持股份管理暂行办法（2025年修订）》《深圳证券交易 所上市公 ...

Key Highlights - Daying Electronics reported current revenue from its unmanned robot business [1] - Hite Bio is planning to issue H-shares and list on the Hong Kong Stock Exchange [1] - Huangshan Tourism is investing approximately 133 million yuan in the upgrade of the Huangshan Tai Ping cableway electrical system [1] - Huatai Technology signed a daily operation contract worth 328 million yuan [1] - Tonghuashun expects a net profit growth of 50%-80% year-on-year for 2025 [1] - Kangxin New Materials plans to acquire 51% equity in Zibang Semiconductor for 392 million yuan [1] - Hengtong Co. intends to repurchase shares worth between 80 million to 100 million yuan [1] - Lanyu Co. shareholders Wang Yinghai and Yushuo Investment plan to reduce their holdings by up to 3% [1][2] - Jinma Amusement plans to raise no more than 1.05 billion yuan through a private placement [2] - Jincai Interconnection plans to raise no more than 570 million yuan through a private placement [2] Investment Projects - Kaizhong Precision plans to upgrade and expand its manufacturing base for new energy vehicle components in Heyuan [1] - Jiangtian Chemical intends to invest in a project with an annual production capacity of 60,000 tons of acrylic acid [1] - Nanjing Julong plans to establish a wholly-owned subsidiary to invest in a modified plastic production line project [1] Performance Forecasts - Batian Co. expects a net profit growth of 117.53% to 139.53% year-on-year for 2025 [1] - Tongfu Microelectronics anticipates a net profit of 1.1 billion to 1.35 billion yuan for 2025, representing a year-on-year growth of 62.34% to 99.24% [1] - Putailai expects a year-on-year increase in net profit of 93.18% to 101.58% for the 2025 fiscal year [1]

Core Viewpoint - On January 20, no A-share listed companies disclosed any increase in shareholding, while 14 companies announced share reductions [1][3]. Summary by Category Share Reduction Details - Beijing Medical intends to reduce its stake by no more than 3% [2][4] - Xinquan shares completed the reduction plan by its investors [2][4] - Blue Universe shareholders plan to collectively reduce their holdings by no more than 3.02% [2][4] - Hongdou shares' shareholder Zhou Haijiang plans to reduce his stake by no more than 0.08% [2][4] - Beijiete's actual controller Zhang Jianfei intends to reduce his stake by no more than 3% [2][4] - Tiancheng Technology shareholders plan to reduce their holdings by no more than 1.6803% [2][4] - Hu Silicon Industry's second-largest shareholder, the Big Fund, reduced its stake by 2% from January 7 to January 19 [2][4] - Hesheng Silicon Industry's controlling shareholder plans to reduce its stake by no more than 3% [2][4] - Aolian Electronics' shareholder Liu Junsheng intends to reduce his stake by no more than 3% [2][4] - Bluefeng Biochemical's shareholder Hainan Wenqin plans to reduce his stake by no more than 3% [2][4] - Zhixin Precision's shareholder Zhou Xin plans to reduce his stake by no more than 3% [2][4] - Nanwei Software's shareholder Qizhong Shiyuan intends to reduce his stake by no more than 1% [2][4] - Desheng Technology's controlling shareholder Hao Xiaobin plans to reduce his stake by no more than 1% [2][4] - Zimi shares' Long'an Trust plans to reduce its holdings by 14.3 million shares [2][4]

证券代码：000788 证券简称：北大医药 公告编号：2026-007 北大医药股份有限公司 关于持股 5%以上股东减持股份的预披露公告 股东北大医疗管理有限责任公司保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示：持有北大医药股份有限公司（以下简称"公司"）股份 63,918,175 股（占公司总股本比例为 10.7247%）的股东北大医疗管理有限责任公司（以下 简称"北大医疗"）计划自本公告披露之日起 15 个交易日后的 3 个月内（即 2026 年 2 月 11 日至 2026 年 5 月 10 日）以集中竞价和大宗交易方式减持公司股份不 超过 17,879,622 股（若此期间公司有送股、资本公积金转增股本等股份变动事 项，将对该数量进行相应调整），占公司总股本比例为 3%。其中，通过集中竞 价方式减持的，在任意连续 90 个自然日内，减持股份总数不超过公司股份总数 的 1%；通过大宗交易方式减持的，在任意连续 90 个自然日内，减持股份总数不 超过公司股份总数的 2%。 公司于近日收到持股 ...

北大医药公告称，持股10.7247%（63,918,175股）的股东北大医疗，因自身资金需求，计划2026年2月 11日至5月10日，以集中竞价和大宗交易方式减持不超17,879,622股，占总股本3%。其中，集中竞价任 意连续90自然日减持不超1%，大宗交易不超2%。本次减持计划实施有不确定性，但不会导致公司控制 权变更，也不影响公司治理和经营。 ...